These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 16247010)

  • 1. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.
    Armanios M; Chen JL; Chang YP; Brodsky RA; Hawkins A; Griffin CA; Eshleman JR; Cohen AR; Chakravarti A; Hamosh A; Greider CW
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15960-4. PubMed ID: 16247010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
    Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
    Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of TERC haploinsufficiency on the inheritance of telomere length.
    Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations.
    Basel-Vanagaite L; Dokal I; Tamary H; Avigdor A; Garty BZ; Volkov A; Vulliamy T
    Haematologica; 2008 Jun; 93(6):943-4. PubMed ID: 18460650
    [No Abstract]   [Full Text] [Related]  

  • 7. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ
    Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.
    Vulliamy T; Marrone A; Goldman F; Dearlove A; Bessler M; Mason PJ; Dokal I
    Nature; 2001 Sep; 413(6854):432-5. PubMed ID: 11574891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.
    Cerone MA; Ward RJ; Londoño-Vallejo JA; Autexier C
    Cell Cycle; 2005 Apr; 4(4):585-9. PubMed ID: 15753647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene.
    Du HY; Pumbo E; Manley P; Field JJ; Bayliss SJ; Wilson DB; Mason PJ; Bessler M
    Blood; 2008 Feb; 111(3):1128-30. PubMed ID: 18042801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts.
    Westin ER; Chavez E; Lee KM; Gourronc FA; Riley S; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Aging Cell; 2007 Jun; 6(3):383-94. PubMed ID: 17381549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome.
    Du HY; Idol R; Robledo S; Ivanovich J; An P; Londono-Vallejo A; Wilson DB; Mason PJ; Bessler M
    Aging Cell; 2007 Oct; 6(5):689-97. PubMed ID: 17875000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
    Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
    Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional telomeres and dyskeratosis congenita.
    Bessler M; Du HY; Gu B; Mason PJ
    Haematologica; 2007 Aug; 92(8):1009-12. PubMed ID: 17650438
    [No Abstract]   [Full Text] [Related]  

  • 16. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.
    He H; Wang Y; Guo X; Ramchandani S; Ma J; Shen MF; Garcia DA; Deng Y; Multani AS; You MJ; Chang S
    Mol Cell Biol; 2009 Jan; 29(1):229-40. PubMed ID: 18936156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita and telomerase.
    Bessler M; Wilson DB; Mason PJ
    Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.
    Walne AJ; Vulliamy T; Marrone A; Beswick R; Kirwan M; Masunari Y; Al-Qurashi FH; Aljurf M; Dokal I
    Hum Mol Genet; 2007 Jul; 16(13):1619-29. PubMed ID: 17507419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
    Hao LY; Armanios M; Strong MA; Karim B; Feldser DM; Huso D; Greider CW
    Cell; 2005 Dec; 123(6):1121-31. PubMed ID: 16360040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.